» Articles » PMID: 1847700

The Effects of Inhibitors of Topoisomerase II and Quinacrine on Ultraviolet-light-induced DNA Incision in Normal and Xeroderma Pigmentosum Fibroblasts

Overview
Specialty Oncology
Date 1991 Jan 1
PMID 1847700
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of our work was to investigate whether DNA topoisomerase II participates in the repair-specific incision of UV-irradiated genomic DNA. Therefore, the influence upon DNA incision of the topoisomerase II inhibitors (nalidixic and oxolinic acid, novobiocin and coumermycin A1) as well as the intercalating agent quinacrine has been measured in normal human fibroblasts using the alkaline elution technique. In addition, inhibition by novobiocin has been determined in fibroblast strains from 11 normal donors and from 16 xeroderma pigmentosum (XP) patients belonging to the complementation groups A, C, D, E, and XP variant. Nalidixic and oxolonic acid did not inhibit endonucleolytic cleavage, whereas novobiocin was a potent inhibitor of DNA incision. It was observed that in normal and in all XP strains 50% inhibition by novobiocin occurred on average in the dose range 315-590 microM. Since inhibition by novobiocin was not paralleled by that with the other topoisomerase II inhibitors nalidixic and oxolinic acid, it must be concluded that reduction of enzyme-catalysed breaks was not due to the participation of topoisomerase II in the incision step, but to the displacement of ATP at the binding site of the DNA-incising enzyme. This enzyme absolutely requires ATP as a cofactor for endonucleolytic cleavage. Quinacrine, however, inhibited DNA incision in normal fibroblasts at a mean Ki of 318 microM. Inhibition by this intercalating agent seems to be caused by structural perturbations in DNA, which render it a poor substrate for endonucleolytic cleavage.

Citing Articles

Influence of quinacrine and chloroquine on the in vitro 3'-azido-3'-deoxythymidine antiretroviral effect.

Torres K, Reyes-Teran G, Sotelo J, Jung-Cook H, Aguirre-Cruz L AIDS Res Ther. 2015; 12:7.

PMID: 25788967 PMC: 4364635. DOI: 10.1186/s12981-015-0048-9.


Application of a novel microtitre plate-based assay for the discovery of new inhibitors of DNA gyrase and DNA topoisomerase VI.

Taylor J, Mitchenall L, Rejzek M, Field R, Maxwell A PLoS One. 2013; 8(2):e58010.

PMID: 23469129 PMC: 3582512. DOI: 10.1371/journal.pone.0058010.

References
1.
Lieberman M . Alterations in chromatin structure during DNA excision repair. Basic Life Sci. 1982; 20:303-14. DOI: 10.1007/978-1-4613-3476-7_20. View

2.
Thielmann H, Edler L, Popanda O, Friemel S . Xeroderma pigmentosum patients from the Federal Republic of Germany: decrease in post-UV colony-forming ability in 30 xeroderma pigmentosum fibroblast strains is quantitatively correlated with a decrease in DNA-incising capacity. J Cancer Res Clin Oncol. 1985; 109(3):227-40. DOI: 10.1007/BF00390362. View

3.
FISCHER E, Thielmann H, Neundorfer B, Rentsch F, Edler L, JUNG E . Xeroderma pigmentosum patients from Germany: clinical symptoms and DNA repair characteristics. Arch Dermatol Res. 1982; 274(3-4):229-47. DOI: 10.1007/BF00403726. View

4.
Snyder R . Is DNA topoisomerase involved in the UV excision repair process? New evidence from studies with DNA intercalating and non-intercalating antitumor agents. Photochem Photobiol. 1987; 45(1):105-11. DOI: 10.1111/j.1751-1097.1987.tb08410.x. View

5.
Popanda O, Thielmann H . Comparison of DNA-incising capacities in fibroblast strains from the Mannheim XP collection after treatment with N-acetoxy-2-acetylaminofluorene and UV light. J Cancer Res Clin Oncol. 1988; 114(5):459-67. DOI: 10.1007/BF00391492. View